Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

During the Trading Day
9.30 +0.01 / +0.11%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
9.30 0.00 / 0.00%
 
Volume: 4.5K

Today’s Trading

Previous close9.29
Today’s open9.32
Day’s range8.79 - 10.00
Volume443,461
Average volume (3 months)594,189
Market cap$511.5M
Dividend yield--
Data as of 4:00pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)-659.09%
Earnings growth (this year)-119.16%
Earnings growth (next 5 years)--
Revenue growth (last year)-39.53%
P/E ratioNM
Price/Sales15.05
Price/Book2.00

Competitors

 Today’s
change
Today’s
% change
SRPTSarepta Therapeutics...+0.11+0.98%
SCMPSucampo Pharmaceutic...+0.22+1.92%
AMPHAmphastar Pharmaceut...+0.13+1.18%
CTMXCytomX Therapeutics ...-0.37-2.76%
Data as of 4:00pm ET, 02/10/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$41.4M
Annual profit (last year)-$55.0M
Net profit margin-132.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Robert B. Bazemore
Executive Director-
Finance
Stephen Garbacz
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers